Gene expression profiling in multiple sclerosis: A disease of the central nervous system, but with relapses triggered in the periphery?

The aetiology of multiple sclerosis (MS), an autoimmune demyelinating disease of the central nervous system (CNS), includes both genetic and environmental factors, but the pathogenesis is still incompletely known. We performed gene expression profiling on paired cerebrospinal fluid (CSF) and peripheral blood mononuclear cells (PBMCs) samples from 26 MS patients without immunomodulatory treatment, sampled in relapse or remission, and 18 controls using Human Genome U133 plus 2.0 arrays (Affymetrix). In the CSF, 939 probe sets detected differential expression in MS patients compared to controls, but none in PBMCs, confirming that CSF cells might mirror the disease processes. The regulation of selected transcripts in CSF of MS patients was confirmed by quantitative PCR. Unexpectedly however, when comparing MS patients in relapse to those in remission, 266 probe sets detected differential expression in PBMCs, but not in CSF cells, indicating the importance of events outside of the CNS in the triggering of relapse.

[1]  J. Nicholson,et al.  Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. , 2006, Physiological genomics.

[2]  S. Chittur,et al.  Bmc Medical Genomics Microarray Analysis in B Cells among Siblings With/without Ms -role for Transcription Factor Tcf2 , 2022 .

[3]  Bart De Moor,et al.  BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis , 2005, Bioinform..

[4]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[5]  Xin Chen,et al.  TRANSFAC: an integrated system for gene expression regulation , 2000, Nucleic Acids Res..

[6]  E. Celius,et al.  Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis , 2010, Genes and Immunity.

[7]  B. Olsson,et al.  Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF , 2008, Journal of Neuroimmunology.

[8]  S. Sriram,et al.  Signaling through JAK2‐STAT5 pathway is essential for IL‐3‐induced activation of microglia , 2004, Glia.

[9]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[10]  T. Olsson,et al.  Differential expression, and genetic association, of CD58 in Swedish multiple sclerosis patients , 2009, Proceedings of the National Academy of Sciences.

[11]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[12]  W. Oertel,et al.  Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. , 2001, Brain : a journal of neurology.

[13]  Cindy L Vnencak-Jones,et al.  Identification of molecular biomarkers for multiple sclerosis. , 2007, The Journal of molecular diagnostics : JMD.

[14]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[15]  Thomas Ragg,et al.  The RIN: an RNA integrity number for assigning integrity values to RNA measurements , 2006, BMC Molecular Biology.

[16]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[17]  R. Sharan,et al.  Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. , 2003, Genome research.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[20]  W. A. LaFramboise,et al.  Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing β-interferon therapy , 2007, Journal of the Neurological Sciences.

[21]  Javed Khan,et al.  Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. , 2003, Human molecular genetics.

[22]  A. Oturai,et al.  Gene expression analysis of interferon-β treatment in multiple sclerosis , 2008, Multiple sclerosis.

[23]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[24]  Tatiana Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[25]  C. Dubois,et al.  Inflammatory Cytokine Production by Human Neutrophils Involves C/EBP Transcription Factors1 , 2009, The Journal of Immunology.

[26]  P. Yankilevich,et al.  Whole genome analysis of the action of interferon-beta. , 2009, International journal of clinical pharmacology and therapeutics.

[27]  Margaret A. Pericak-Vance,et al.  The role of the CD58 locus in multiple sclerosis , 2009, Proceedings of the National Academy of Sciences.

[28]  F. V. Van Dolah,et al.  Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR , 2006, Biological Procedures Online.

[29]  Patrick W. Faloon,et al.  Mouse lysocardiolipin acyltransferase controls the development of hematopoietic and endothelial lineages during in vitro embryonic stem-cell differentiation. , 2007, Blood.

[30]  A. Achiron,et al.  Impaired Expression of Peripheral Blood Apoptotic‐Related Gene Transcripts in Acute Multiple Sclerosis Relapse , 2007, Annals of the New York Academy of Sciences.

[31]  Crispin J. Miller,et al.  Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis , 2005, Bioinform..

[32]  G. Stewart,et al.  Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission , 2008, BMC Medical Genetics.

[33]  J. Satoh,et al.  Molecular Network Analysis of T-Cell Transcriptome Suggests Aberrant Regulation of Gene Expression by NF-κB As a Biomarker for Relapse of Multiple Sclerosis , 2008, Disease markers.

[34]  A Achiron,et al.  Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. , 2006, Autoimmunity reviews.

[35]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[36]  James Wason,et al.  Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor , 2009, European Journal of Human Genetics.

[37]  Sue Povey,et al.  The HGNC Database in 2008: a resource for the human genome , 2007, Nucleic Acids Res..

[38]  J. Bright,et al.  Quercetin, a Flavonoid Phytoestrogen, Ameliorates Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through JAK-STAT Pathway in T Lymphocyte , 2004, Journal of Clinical Immunology.

[39]  L. Flowers,et al.  Treatment of Mice with the Suppressor of Cytokine Signaling-1 Mimetic Peptide, Tyrosine Kinase Inhibitor Peptide, Prevents Development of the Acute Form of Experimental Allergic Encephalomyelitis and Induces Stable Remission in the Chronic Relapsing/Remitting Form1 , 2005, The Journal of Immunology.

[40]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[41]  Pablo Tamayo,et al.  Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. , 2008, Brain : a journal of neurology.

[42]  A. Dejean,et al.  A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis , 2009, Science Translational Medicine.

[43]  Kazumasa Yokoyama,et al.  T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients , 2006, Journal of Neuroimmunology.

[44]  C. Du,et al.  Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis. , 1999, Journal of immunology.

[45]  Rekha C. Patel,et al.  Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. , 2007, Atherosclerosis.

[46]  T. Lehtimäki,et al.  Gene expression profiles in Finnish twins with multiple sclerosis , 2006, BMC Medical Genetics.

[47]  J. Bright,et al.  Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation , 2002, Genes and Immunity.